30s Ad: $29 - $36
60s Ad: $35 - $41
CPM Category: Health & Fitness
Different podcast categories command different CPM (cost per mille) rates based on advertiser demand and audience value.
Business Trip tells the story of businesses at the frontier of mental health and brain health. Each episode features founders, investors, and researchers in psychedelics, neurotechnology, metabolic psychiatry, digital therapeutics, and more.
Business Trip tells the story of businesses at the frontier of mental health and brain health. Each episode features founders, investors, and researchers in psychedelics, neurotechnology, metabolic psychiatry, digital therapeutics, and more.
Producers, Hosts, and Production Team
Searching
Searching for producer information... This may take a moment.
Producers, Hosts, and Production Team
No producer information available yet. Click "Find producers" to search for the production team.
Emails, Phones, and Addresses
Contact Page Emails
Emails listed specifically on the website's official contact page.
Emails
Phone Numbers
No phone numbers found.
Addresses
No addresses found.
Form
No form detected on this page.
General Website Emails
Emails found on general website pages (e.g., about, info), not the main contact page.
No website emails found.
Externally Sourced Emails
Emails discovered using automated web scraping across the internet.
gr***@businesstrip.fm
RSS Emails
Email addresses extracted directly from the website's or podcast's RSS feed(s).
No RSS emails found.
Recent Hosts, Guests & Topics
Here's a quick summary of the last 3 episodes on Business Trip.
Hosts
Matias Serebrinsky
Greg Kubin
Previous Guests
Justin Mares
Justin Mares is the co-founder of TrueMed and Kettle & Fire, companies focused on improving health through innovative food products and healthcare solutions. He has a background in entrepreneurship and investment, with a keen interest in how startups can disrupt traditional healthcare systems. Justin is known for his contrarian views on health and wellness, advocating for changes in the food system and addressing the incentives within the pharmaceutical industry.
Justin Mares is the co-founder of TrueMed and Kettle & Fire, companies focused on improving health through innovative food products and healthcare solutions. He has a background in entrepreneurship and investment, with a keen interest in how startups can disrupt traditional healthcare systems. Justin is known for his contrarian views on health and wellness, advocating for changes in the food system and addressing the incentives within the pharmaceutical industry.
Brooks Leitner
Brooks Leitner is a partner at PsyMed Ventures, bringing a wealth of experience from his background as an MD/PhD. He has a strong academic foundation with training from Yale University and the National Institutes of Health (NIH). His expertise lies in the intersection of neuroscience and venture capital, focusing on innovative approaches to brain and mental health therapies. Brooks advocates for a human-first approach in research and investment, emphasizing the importance of clinical insights over traditional animal models.
Brooks Leitner is a partner at PsyMed Ventures, bringing a wealth of experience from his background as an MD/PhD. He has a strong academic foundation with training from Yale University and the National Institutes of Health (NIH). His expertise lies in the intersection of neuroscience and venture capital, focusing on innovative approaches to brain and mental health therapies. Brooks advocates for a human-first approach in research and investment, emphasizing the importance of clinical insights over traditional animal models.
Nir Grossman
No additional bio available.
Topics Discussed
US healthcare
startups
chronic illness
food system
environmental toxins
pharma incentives
brain health
body health
mental health
PsyMed Ventures
neuroscience innovation
venture investing
therapeutics
medical devices
diagnostics
consumer health
AI-enabled care platforms
temporal interference
brain stimulation
neurotechnology
non-invasive stimulation
deep brain stimulation
Alzheimer's
epilepsy
depression
traumatic brain injury
What's wrong with US healthcare and how startups can fix it, with Justin Mares
Hosts
Hosts of this podcast episode
Matias SerebrinskyGreg Kubin
Guests
Guests of this podcast episode
Justin Mares
Keywords
Keywords of this podcast episode
US healthcarestartupschronic illnessfood systemenvironmental toxinspharma incentivesbrain healthbody health
Greg and Matias interview Justin Mares, co-founder of TrueMed and Kettle & Fire on current US healthcare and how startups have the opportunity to change the system.
In this episode, we discuss:
How the US system profits from chronic illness
Fixing the food system, environmental toxins, pharma incentives & more
Opportunities for founders building in brain and body health.
Greg and Matias interview Justin Mares, co-founder of TrueMed and Kettle & Fire on current US healthcare and how startups have the opportunity to change the system.
In this episode, we discuss:
How the US system profits from chronic illness
Fixing the food system, environmental toxins, pharma incentives & more
Opportunities for founders building in brain and body health.
Frontier investable areas in brain health with PsyMed Ventures
Hosts
Hosts of this podcast episode
Matias SerebrinskyGreg Kubin
Guests
Guests of this podcast episode
Brooks Leitner
Keywords
Keywords of this podcast episode
brain healthmental healthPsyMed Venturesneuroscience innovationventure investingtherapeuticsmedical devicesdiagnosticsconsumer healthAI-enabled care platforms
Greg and Matias sit down with Brooks Leitner, the newest venture partner at PsyMed Ventures, to explore the future of brain and mental health investing. Brooks, an MD/PhD with deep experience from Yale and the NIH, shares his insights on how a human-first approach is reshaping neuroscience innovation and venture investing.
In this episode, we discuss:
Broadening the Thesis: Evolving from a psychedelics-only focus to a comprehensive neuro investment strategy.
Human-First Research: Shifting from animal models to clinical insights for better brain therapies.
Key Investment Areas: Therapeutics, medical devices, diagnostics, consumer health, and AI-enabled care platforms.
Early-Stage Conviction: Leveraging a prepared mind to spot breakthrough opportunities.
Personal & Future Insights: Leadership challenges and the vision for the future of neuro investing.
Greg and Matias sit down with Brooks Leitner, the newest venture partner at PsyMed Ventures, to explore the future of brain and mental health investing. Brooks, an MD/PhD with deep experience from Yale and the NIH, shares his insights on how a human-first approach is reshaping neuroscience innovation and venture investing.
In this episode, we discuss:
Broadening the Thesis: Evolving from a psychedelics-only focus to a comprehensive neuro investment strategy.
Human-First Research: Shifting from animal models to clinical insights for better brain therapies.
Key Investment Areas: Therapeutics, medical devices, diagnostics, consumer health, and AI-enabled care platforms.
Early-Stage Conviction: Leveraging a prepared mind to spot breakthrough opportunities.
Personal & Future Insights: Leadership challenges and the vision for the future of neuro investing.
Greg and Matias interview Dr. Nir Grossman, one of the world’s leading researchers in neurotechnology. Nir is a lecturer in the Department of Brain Sciences at Imperial College London and a founding fellow of the UK Dementia Research Institute.
In this episode, we discuss:
What is temporal interference (TI), a non-invasive stimulation method
A comparison of TI with deep brain stimulation (DBS)
How physics plays a crucial role in neuroscience innovation
Translating TI academic research to clinical use
TI’s role in treating Alzheimer’s, epilepsy, depression, and traumatic brain injury
Greg and Matias interview Dr. Nir Grossman, one of the world’s leading researchers in neurotechnology. Nir is a lecturer in the Department of Brain Sciences at Imperial College London and a founding fellow of the UK Dementia Research Institute.
In this episode, we discuss:
What is temporal interference (TI), a non-invasive stimulation method
A comparison of TI with deep brain stimulation (DBS)
How physics plays a crucial role in neuroscience innovation
Translating TI academic research to clinical use
TI’s role in treating Alzheimer’s, epilepsy, depression, and traumatic brain injury